February 4, 2019 – Wolters Kluwer, Health announced today that the Journal of Psychosocial Oncology Research & Practice, the newest journal of the International Psycho-Oncology Society (IPOS), will be published under the Lippincott portfolio.
The Journal of Psychosocial Oncology Research & Practice is an open access journal focused on the growing body of research in the field of psychosocial oncology. The journal publishes articles reporting on clinical research examining psychosocial and behavioral interventions in oncology settings, research on the implementation of psychosocial and behavioral interventions in routine clinical practice and their impact on outcomes.
“Building on the growing strength of research in the field of psycho-oncology internationally, this exciting, new, open-access journal aims to promote dissemination of the highest quality up-to-date research relevant to improving clinical practice in cancer care globally,” says Brian Kelly, Co-Editor-in-Chief. “This could be a game changer in accelerating the rate of dissemination and uptake of new and innovative psychosocial interventions relevant to a global audience,” adds Linda Carlson, Co-Editor-in-Chief.
The Journal of Psychosocial Oncology Research and Practice will include reports on pragmatic clinical trials, qualitative research, systematic reviews, survivorship research and care, psychosocial oncology research and practice in developing countries, innovative research methods and research into global and regional health disparities as they relate to psychosocial oncology care and services.
“The Journal of Psychosocial Oncology Research & Practice is an essential resource for disseminating updated and multidisciplinary clinical practice and research in psycho-oncology,” said Maria Die Trill, IPOS President. “Easier access to clinical research publications through open-access papers will provide professionals in developing countries with a significant source of knowledge where accessing subscription-based journals is often difficult. Together with Wolters Kluwer, the journal´s experienced co-editors, and our international editorial board we will assure continued excellence.”
The journal is now open for manuscript submissions. For more information visit: https://www.editorialmanager.com/jporp/default.aspx.
###
About the International Psycho-Oncology Society (IPOS)
Founded in 1984, the IPOS was created to foster international multidisciplinary communication about clinical, educational and research issues that relate to the subspecialty of psycho-oncology and two primary psychosocial dimensions of cancer:
- Response of patients, families and staff to cancer and its treatment at all stages
- Psychological, social and behavioral factors that influence tumor progression and survival
With members in almost 100 countries worldwide, IPOS has established itself as an international voice for psychosocial oncology professionals. For more information about IPOS, find us online at https://ipos-society.org/ and follow us on LinkedIn and Twitter @IPOSPsychoOncol.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information, software solutions, and services for the health, tax & accounting, finance, risk & compliance, and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer, headquartered in the Netherlands, reported 2017 annual revenues of €4.4 billion. The company serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide.
Wolters Kluwer Health is a leading global provider of trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.
